Ani Pharmaceuticals ANIP
NASDAQ ANIP
$70.28 +0.05 (+0.07%)
As of: Sep 9, 2026 · 3:47 PM EDT

Ani Pharmaceuticals (ANIP) Dividend Coverage Ratio Growth (3y) (2024 - 2025)

Analysis

Ani Pharmaceuticals (ANIP) Dividend Coverage Ratio Growth (3y) (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div. Cover Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 42.81 Bn 39.16 Bn 2.15 Bn -
2 Viatris 19.17 Bn 18.28 Bn 1.46 Bn -35.05%
3 Dr Reddys Laboratories 9.90 Bn 9.73 Bn 396.53 Mn -
4 Amneal Pharmaceuticals 5.47 Bn 5.35 Bn 334.51 Mn -
5 Bausch Health Companies 2.32 Bn 479.50 Mn 2.10 Bn -
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -
7 Ani Pharmaceuticals 1.49 Bn 1.12 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 997.70 Mn 707.58 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 395.89 Mn 354.64 Mn 17.15 Mn -
10 RedHill Biopharma 179.21 Mn 179.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 75.91%
Jun 30, 2025 36.28%
Mar 31, 2025 39.97%
Dec 31, 2024 40.99%